9％）であった。 （2）12歳以上の通年性アレルギー性鼻炎患者を対象とした第III相二重盲検比較試験の結果、医師評価による2週間投与後の4鼻症状スコアの合計のベースラインからの変化量において、デスロラタジン5mgの1日1回投与は ...

処方薬事典は、日経メディカル Onlineが配信する医療・医薬関係者向けのコンテンツです。一般の方もご覧いただけますが、内容に関するご質問に ...

Find all the commercial and brand names of generic drug called Loratadine. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

You may report side effects to Health Canada at 1-866-234-2345. Loratadine does not usually cause drowsiness when used at recommended doses. However, do not drive, use machinery, or do anything ...

Loratadine 5mg, pseudoephedrine sulfate 120mg; ext-rel tabs. Hepatic or renal impairment. Hypertension. Ischemic heart disease. Increased intraocular pressure. Thyroid disease. GI or urinary ...

299 patients with severe allergic rhinitis were randomly allocated to either betamethasone 1.0mg or betamethasone 1.0mg plus loratadine 10mg or betamethasone 0.5mg plus loratadine 10mg or ...

Aims: To assess the effect of loratadine in exercise induced asthma. Methods: Randomised, double blind, placebo controlled study of 10 mg oral loratadine, once daily for three days in 11 children. At ...

You may report side effects to Health Canada at 1-866-234-2345. Loratadine does not usually cause drowsiness when used at recommended doses. However, do not drive, use machinery, or do anything ...

Loratadine 5mg; chew tabs; grape flavor, bubble-gum flavor; contains phenylalanine 1.4mg/tab. Tabs—5, 10, 20, 30, 45, 70, 90; RediTabs 24-Hour—5, 10, 30, 45, 70 ...

Objective: To compare loratadine with fexofenadine and placebo in relieving symptoms of seasonal allergic rhinitis (SAR). Design: A randomised, double-blind, double-dummy, placebo-controlled ...